News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cochlear Limited Gets FDA Approval for Nucleus 5


9/4/2009 6:58:33 AM

Bookmark and Share

Pharmabiz.com -- Cochlear Limited, the global leader in cochlear and bone conduction implant technology, announced that it will launch three new technologies - Cochlear Nucleus 5, Cochlear Baha BP100 and Cochlear Hybrid - in India within a month. Trials of these products were already conducted over the period of 10 years in India. Already 3500 hearing impaired patients are the recipients of these implant technologies in the country.

Read at PharmaBiz


comments powered by Disqus
PharmaBiz
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES